This mechanism is associated with direct inhibition of SOX12 expression and attenuation of the Wnt/β-catenin pathway, suggesting a potential role of miR-744-5p as a regulator of aggressiveness and metabolism in hematological malignancies. Here, SOX12 is linked to hematologic disorder.